Conservative Management of Vestibular Schwannoma: Expectations Based on the Length of the Observation Period

被引:2
作者
Fayad, Jose N. [1 ,2 ]
Semaan, Maroun T. [3 ]
Lin, James [4 ]
Berliner, Karen I. [5 ]
Brackmann, Derald E. [1 ,2 ]
机构
[1] House Res Inst, Los Angeles, CA USA
[2] House Clin, Los Angeles, CA 90057 USA
[3] Univ Hosp Case Med Ctr, Case Western Reserve Sch Med, Ear Nose & Throat Inst, Cleveland, OH USA
[4] Univ Kansas, Med Ctr, Dept Otolaryngol Head & Neck Surg, Kansas City, KS 66103 USA
[5] House Res Inst, Marina Del Rey, CA USA
关键词
Acoustic tumor; Conservative management; Natural history; Tumor growth; Tumor observation; Vestibular schwannoma; Wait-and-see; NATURAL-HISTORY; HEARING; GROWTH; PREDICTORS;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Evaluate long-term prevalence of tumor growth and need for further treatment in patients with a vestibular schwannoma treated with conservative management. Study Design: Retrospective chart review. Setting: Private neurotologic tertiary referral center. Patients: Vestibular schwannoma patients undergoing conservative management and previously studied (N = 114). Mean time to last magnetic resonance imaging was 4.8 years and to last follow-up was 6.4 years (maximum, 18.5 yr). Intervention: Serial gadolinium-enhanced magnetic resonance imaging with size measurement. Main Outcome Measures: Change in maximum tumor dimension of 2 mm or higher (growth), further treatment, audiologic measures-pure-tone average, word recognition, AAO-HNS (American Academy of Otolaryngology-Head and Neck Surgery) hearing class. Results: Thirty-eight percent of tumors demonstrated growth; an average of 6.5 mm (SD, 3.8) at a mean rate of 3.1 mm per year. Of patients with no growth at 1 year or less, 20% grew by last follow-up. Overall, 31% had further treatment after a mean of 3.8 years (SD, 3.5; maximum, 18.5 yr). Of those followed for 5 to 10 years, 18% eventually had further treatment. Only 56% of growing tumors had further treatment by last follow-up; 14.8% with nongrowing tumors also had further treatment. Pure-tone average declined more in tumors that grew (mean Delta = 28.8 dB) than those that did not (mean Delta = 16.5 dB) (p <= 0.025), but there was no correlation between the amount of change in hearing and in the size of the tumor. Of patients with an initial AAO-HNS hearing Class A, 85.7% retained serviceable hearing. Conclusion: For patients electing an observation approach to treatment of vestibular schwannoma, about 31% may eventually undergo further treatment. Of those followed for 5 to 10 years, 18% eventually had further treatment. However, some patients are followed with radiologic evaluations for many years without necessity for further treatment.
引用
收藏
页码:1258 / 1265
页数:8
相关论文
共 18 条
  • [1] Predictors of Vestibular Schwannoma Growth and Clinical Implications
    Agrawal, Yuri
    Clark, James H.
    Limb, Charles J.
    Niparko, John K.
    Francis, Howard W.
    [J]. OTOLOGY & NEUROTOLOGY, 2010, 31 (05) : 807 - 812
  • [2] Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment Clinical article
    El Bakkouri, Wissame
    Kania, Romain E.
    Guichard, Jean-Pierre
    Lot, Guillaume
    Herman, Philippe
    Huy, Patrice Tran Ba
    [J]. JOURNAL OF NEUROSURGERY, 2009, 110 (04) : 662 - 669
  • [3] Charabi S, 2000, ACTA OTO-LARYNGOL, P7
  • [4] Fucci MJ, 1999, AM J OTOL, V20, P495
  • [5] A New Standardized Format for Reporting Hearing Outcome in Clinical Trials
    Gurgel, Richard K.
    Jackler, Robert K.
    Dobie, Robert A.
    Popelka, Gerald R.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2012, 147 (05) : 803 - 807
  • [6] Size and growth rate of sporadic vestibular schwannoma: Predictive value of information available at presentation
    Herwadker, A
    Vokurka, EA
    Evans, DGR
    Ramsden, RT
    Jackson, A
    [J]. OTOLOGY & NEUROTOLOGY, 2005, 26 (01) : 86 - 92
  • [7] Clinical, Radiographic, and Audiometric Predictors in Conservative Management of Vestibular Schwannoma
    Malhotra, Prashant S.
    Sharma, Pranav
    Fishman, Michael A.
    Grumbine, F. Lawson
    Tholey, Renee
    Dam, Vincent Q.
    Dasgupta, Abhijit
    Pequignot, Edward
    Willcox, Thomas O.
    [J]. OTOLOGY & NEUROTOLOGY, 2009, 30 (04) : 507 - 514
  • [8] A Protocol for the Conservative Management of Vestibular Schwannomas
    Martin, Thomas P. C.
    Senthil, Latha
    Chavda, Swarapsinh V.
    Walsh, Richard
    Irving, Richard M.
    [J]. OTOLOGY & NEUROTOLOGY, 2009, 30 (03) : 381 - 385
  • [9] Small acoustic neuromas: Surgical outcomes versus observation or radiation
    Meyer, TA
    Canty, TA
    Wilkinson, EP
    Hansen, JR
    Rubinstein, JT
    Gantz, JJ
    [J]. OTOLOGY & NEUROTOLOGY, 2006, 27 (03) : 380 - 392
  • [10] MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P179